Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Allogeneic Stem Cell Transplantation, AML

Frederick Appelbaum

MD

🏢Fred Hutchinson Cancer Center🌐USA

Executive Vice President and Deputy Director

72
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Frederick Appelbaum at Fred Hutch has contributed to allogeneic hematopoietic stem cell transplantation (HSCT) as treatment for AML and other hematologic malignancies, including work on graft-versus-leukemia effect, treatment conditioning regimens, and post-transplant care. His contributions to the science and practice of bone marrow transplantation have been foundational for curative treatment of high-risk hematologic cancers.

Share:

🧪Research Fields 研究领域

allogeneic bone marrow transplant AML
hematopoietic stem cell transplantation
graft versus leukemia GVL
donor lymphocyte infusion
cord blood transplantation

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Frederick Appelbaum 的研究动态

Follow Frederick Appelbaum's research updates

留下邮箱,当我们发布与 Frederick Appelbaum(Fred Hutchinson Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment